Clinical Biosafety Services, a subsidiary of Sabai Global

Gene Therapy. Accelerated. Clinical Biosafety Services provides Institutional Biosafety Committee (IBC) Review and Biosafety Consulting Services. Our mission and expertise at Clinical Biosafety Services is to provide accelerated, compliant review of gene transfer/gene therapy clinical trials to a convened review of a site-specific Institutional Biosafety Committee (IBC). We do this by understanding the challenges in the two client relationship of serving an institution and a sponsor. Our focus is to accelerate the trial, and remove regulatory burden and uncertainty by having our highly trained experts provide friendly, knowledgeable support during the review process. We understand these therapeutics will change medicine,...

Institutional biosafety committee review services,biosafety consulting,ibc,and gene therapy

Clinical biosafety services, a subsidiary of sabai global operates in the Biotechnology research industry.

Clinical biosafety services, a subsidiary of sabai global's revenue is 11m - 100m

Clinical biosafety services, a subsidiary of sabai global has 11 - 50 employees.